قائمة الأدوية تحت التسجيل
قائمة الأدوية تحت التسجيل
| الاسم العلمي | الشكل الصيدلاني | التركيز |
|---|---|---|
Toxoid of Clostridium tetani/ Anaculture of Clostridium chauvoei/ B toxoid of Clostridium perfringens type B C and D/ E toxoid of Clostridium perfringens type B C and D/ a toxoid of Clostridium novyi type B/ a toxoid of Clostridium septicum |
Suspension for injection |
nlt 2.5ml , 100ml , nlt 10ml , nlt 5ml , nlt 3.5ml , nlt 2.5ml |
Mycoplasma agalactiae ovis inactivated strain 784 |
Suspension for injection |
1.5ml |
gE negative BHV1 strain GKD |
Lyophilisate and solvent for suspension for injection |
10^5.7TCID50 |
Inactivated Histophilus somni Bailie strain/ Mannheimia haemolytica Biotype A serotype A1 inactivated cell free suspension containing leukotoxoid |
Emulsion for injection |
3.3ml , 2.8ml |
Inactivated Newcastle disease virus strain NDV-SZ LaSota-/ Inactivated bursal disease virus strain GP 82 - |
Emulsion for infusion |
4 log2 HItitre , 3 log10 VNtitre |
Newcastle clisease virus strain PHY LMV 42/ Avian infectious bronchitis virurs strain Hl20 |
Suspension and solution for spray |
5.5 log 10EID50/dose , 3.3 log 10EID50/dose |
Inactivated Newcastle disease viruS strain NDV-SZ LaSota/Inactivated avian infectious bronchitis virus strain M-41 |
Emulsion for injection |
4 log2 HItitre , 6 log 2 HItitre |
Avian infectious bursal disease virus strain Winterfield 2512 G-61 |
Lyophilisate for use in drinking water |
min. 2.0EID50/dose |
Newcastle disease virus apathogenic PHY LMV 42 strain |
Suspension for use in drinking water |
5.5 log 10log10 EID50/dose |
Infectious Bronchitis Virus strain H120 |
Lyophilisate for use in drinking water |
3 - 4.7EID50/dose |